SIREN : 479974552
EURMEDES is a French company founded 21 years ago, specialized in the sector Conseil pour les affaires et autres conseils de gestion. Based in LE MEE-SUR-SEINE (77350), this company of category PME shows in 2023 a revenue of 100 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicador | 2023 | 2019 |
|---|---|---|
| Ingresos | 100 140 € | 57 147 € |
| Resultado neto | 11 610 € | -6 713 € |
| EBITDA | 12 287 € | -6 714 € |
| Margen neto | 11.6% | -11.7% |
In 2023, EURMEDES achieves revenue of 100 k€. Vs 2019, growth of +75% (57 k€ -> 100 k€). After deducting consumption (0 €), gross margin stands at 100 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 12 k€, representing 12.3% of revenue. Positive scissor effect: EBITDA margin improves by +24.0 pts, sign of improved operational efficiency. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 12 k€, i.e. 11.6% of revenue. This profit can be retained or distributed to shareholders.
100 140 €
100 140 €
12 287 €
13 727 €
11 610 €
12.3%
The debt ratio (= Financial debt / Equity x 100) stands at 31%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.9 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 11.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
30.892%
65.838%
11.594%
1.887
In 2023, the debt ratio of EURMEDES (30.89) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2023, the financial autonomy of EURMEDES (65.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2023, the repayment capacity of EURMEDES (1.89) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 723.17. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.6x. Danger: operating income does not cover interest charges, unsustainable situation.
723.169
0.553
In 2023, the liquidity ratio of EURMEDES (723.17) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2023, the interest coverage of EURMEDES (0.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 55 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 31 days. The company must finance 24 days of gap between collections and payments. Overall, WCR represents 21 days of revenue, i.e. 6 k€ to permanently finance.
5 715 €
55 j
31 j
0 j
21 j
Based on 66 transactions of similar company sales
in 2023,
the value of EURMEDES is estimated at
59 438 €
(range 20 671€ - 107 049€).
With an EBITDA of 12 287€, the sector multiple of 4.0x is applied.
The price/revenue ratio is 0.63x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 66 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare EURMEDES with other companies in the same sector:
Voir toutes les statistiques du secteur Conseil pour les affaires et autres conseils de gestion
The revenue of EURMEDES in 2023 is 100 k€.
Yes, EURMEDES generated a net profit of 12 k€ in 2023.
The headquarters of EURMEDES is located in LE MEE-SUR-SEINE (77350), in the department Seine-et-Marne.
The tax return of EURMEDES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
EURMEDES operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.